Replimune (REPL) Treasury Shares (2018 - 2026)
Replimune (REPL) reported Treasury Shares of $5.5 million for Q1 2026, up 52.53% on a YoY basis from $3.6 million in Q1 2025, and down 2.72% sequentially from $5.7 million in Q4 2025.
Replimune (REPL) Treasury Shares (2018 - 2026) Analysis & Trends
Replimune (REPL) has 7 years of Treasury Shares data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 52.53% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 52.53% YoY), and the FY2026 full-year result was $5.5 million, up 52.53% from the prior year.
- Treasury Shares declined to $5.5 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $5.7 million in Q4 2025 to a low of $826213.0 in Q1 2022.
- A 5-year average of $3.0 million and a median of $2.4 million in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares surged 5071.91% in 2022 and jumped 46.07% in 2025, its largest moves.
- Tracing REPL's Treasury Shares over 5 years: stood at $1.4 million in 2022, then surged by 50.77% to $2.0 million in 2023, then soared by 71.06% to $3.5 million in 2024, then surged by 62.2% to $5.7 million in 2025, then decreased by 2.72% to $5.5 million in 2026.
- Business Quant data shows REPL's Treasury Shares at $5.5 million in Q1 2026, $5.7 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 5.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.51 Mn |
| Mar 31, 2026 | 5.51 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |